Últimas noticias sobre IQVIA Hldgs (NYSE:IQV) Bolsa

IQVIA Hldgs

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

IQVIA Holdings

IQVIA Holdings Inc

Wells Fargo analyst Michael Turrin maintains Confluent (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFLT#NASDAQ">CFLT</a>) with a Overweight and lowers the price target from $42 to $32.

News

Price Target

Analyst Ratings

CFLT

Wells Fargo Maintains Overweight on Confluent, Lowers Price Target to $32

At least one analyst says Take-Two Interactive Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTWO#NASDAQ">TTWO</a>) and Roblox Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) are best positioned to ride out whatever macro headwinds the gaming sector goes through, such as <a href="https://www.benzinga.com/general/gaming">potential console cost hikes</a>.
As markets brace for market turbulence and the tariff chatter gets louder, JPMorgan's Cory Carpenter says the gaming sector may not take a full hit but will still feel some rumble.
While the low cost and hit-driven nature of video games helped them hold steady during the 2008/09 downturn, things are more complicated now thanks to the rise of mobile and live services. 
"AAA titles and free-to-play mobile games will likely prove most resilient," Carpenter says, while in-app purchases and catalog titles could take a hit.
But within this mixed bag, some stocks are still flashing green.
Read Also: <a href="https://www.benzinga.com/25/04/44672218/gamestop-enters-the-danger-zone-death-cross-flashes-but-ryan-cohen-isnt-flinching">GameStop Enters The Danger Zone: Death Cross Flashes, But Ryan Cohen Isn&#8217;t Flinching</a>
<h2 class="wp-block-heading">GTA Hype Keeps Take-Two In The Game</h2>
Take-Two remains a top pick. Carpenter sees a potential upside surprise this quarter, thanks to steady NBA 2K trends and a surprise mobile breakout in Color Block Jam. Zynga's migration to AppLovin Corp's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) mediation platform might also quietly boost Take-Two's mobile business.
Of course, all eyes remain on GTA VI. Investor nerves are growing as the Fall 2025 window nears with no second trailer. Carpenter thinks a Winter release won't shake the stock too much &#8211; but early 2026? That's another story.
JPMorgan holds its $225 price target steady, assuming 36 million GTA VI units at $70 apiece &#8211; numbers that might even prove conservative.
<h2 class="wp-block-heading">Roblox Levels Up With User Surge, Ad Power-Up</h2>
Roblox is the only name in JPM's coverage where estimates are getting a real upgrade. Daily active users just hit a record 97 million, and that's a strong setup for a first-quarter beat.
The newly launched rewarded video ads and programmatic ad partnership with Alphabet Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) Google could turbocharge 2025 results. 
Carpenter nudges his full-year bookings estimate to $5.296 billion &#8211; at the high end of company guidance.
<h2 class="wp-block-heading">EA Gets FC Boost, Playstudios Stays In Penalty Box</h2>
Electronic Arts Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EA#NASDAQ">EA</a>) sees a modest lift to its price target ($135) on stronger FC trends, helped by frequent content updates that re-energized player sentiment. But with no word on when Battlefield will deploy, JPMorgan is keeping its FY26 outlook cautious. 
Meanwhile, Playstudios Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYPS#NASDAQ">MYPS</a>) stays on the bench with an Underweight rating as in-app purchase revenue continues to fall. Without a breakout from its upcoming Sweepstakes and Tetris titles, JPMorgan expects 2025 revenue to hover at the low end of guidance.
While macro clouds linger over gaming, JPMorgan sees selective bright spots &#8211; particularly in Roblox and Take-Two. For investors, it's less about beating the market and more about backing the right boss battle.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/25/04/44903063/star-wars-highlights-tv-new-movie-with-ryan-gosling-fortnite-collab-will-the-force-be-with-disney-stock">Star Wars Highlights TV, New Movie With Ryan Gosling, Fortnite Collab: Will The Force Be With Disney Stock?</a></li>
</ul>
Image: Shutterstock

Analyst Color

Gaming

Long Ideas

Trading Ideas

General

GOOG

GOOGL

MYPS

RBLX

TTWO

Roblox, Take-Two Level Up: But Can Gaming Stocks Survive A Macro Boss Fight?

Evercore ISI Group analyst Jonathan Chappell maintains Ardmore Shipping (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASC#NYSE">ASC</a>) with a Outperform and lowers the price target from $14 to $13.

Evercore ISI Group Maintains Outperform on Ardmore Shipping, Lowers Price Target to $13

This ace institutional investor — a former head of research at Nomura and Bridgewater Associates and served as a managing director at Goldman Sachs — says he has &#8220;never before observed&#8221; the trio of falling equities, rising long-term Treasury yields, and declining short-term yields.
What Happened: Jens Nordvig, who is currently the founder and CEO of Exante Data and MarketReader, has highlighted a rare combination between yields and equities that has gripped the market with worries.
As the 30-Year Treasury yield hovered around 4.89% and the two-year Treasury yielded 3.80%, this phenomenon signaled a normal scenario with higher long-term yields and lower short-term yields.
However, this normal curve was followed by a fall in equities as the S&amp;P 500 index was 16.09% lower than its previous record of 6,147.43 points, and the Nasdaq 100 was down 19.86% from its all-time high of 22,222.61 points.
Also, the Dow Jones was 18.09% below its 52-week high of 45,073.63 points.
&#8220;Over the last few decades, we have never before observed the combination of dramatic equity declines, declining short-end yields, and notable rises in 30Y rates. Nothing is normal about this,&#8221; said Nordvig.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">30Y bond yields were up another 10bp on Monday, to 4.90%. For the month of April, the 30Y yield is up 33bp, even if the S&amp;P500 is down around 10%. Over the last few decades, we have never before observed the combination of dramatic equity declines, declining short-end yields,… <a href="https://t.co/epgOUrTBde">pic.twitter.com/epgOUrTBde</a>
&mdash; Jens Nordvig (@jnordvig) <a href="https://twitter.com/jnordvig/status/1914441620730097678?ref_src=twsrc%5Etfw">April 21, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/government/regulations/25/04/44918830/jim-cramer-takes-a-dig-at-trumps-criticism-of-powell-you-would-actually-buy-this-rally-if-trump-hadnt-criticized-the-fed-chair">Jim Cramer Takes A Dig At Trump&#8217;s Criticism Of Powell: &#8216;You Would Actually Buy This Rally&#8217; If Trump Hadn&#8217;t Criticized The Fed Chair</a>
Why It Matters: While an inverted yield curve triggers a correction and points to a possible recession, a normal curve where long-term bond yields are higher than short-term yields is associated with a period of economic growth and increased corporate earnings and stock valuations.
Thus, the condition highlighted by Nordvig was an outlier, which was also accompanied by the falling value of the U.S. dollar.
Another unlikely pattern that has emerged is the <a href="https://www.benzinga.com/government/regulations/25/04/44895384/dollar-slips-to-a-three-year-low-below-98-mark-higher-rates-are-not-supporting-the-dollar-says-expert">divergence of rising yields</a> with respect to the strength of the U.S. dollar.
This was described as the &#8220;measure of stress in markets&#8221; by Jim Bianco, the president and founder of Bianco Research LLC.
&#8220;Higher rates are not supporting the dollar right now. This means they might have to go a lot higher to stop the dollar from falling,&#8221; he added.
Typically, higher yields strengthen the dollar via foreign demand for USD assets like Treasuries; however, Bianco&#8217;s chart highlights a concerning divergence.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">1/2 The breaking of this relationship is a measure of stress in markets &#8230; it continues to widen.(Higher rates are not supporting the dollar right now. This means they might have to go a lot higher to stop the dollar from falling.) <a href="https://t.co/PRj6mYNu0J">pic.twitter.com/PRj6mYNu0J</a>
&mdash; Jim Bianco (@biancoresearch) <a href="https://twitter.com/biancoresearch/status/1914160730535756287?ref_src=twsrc%5Etfw">April 21, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Price Action: The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, rose in premarket on Tuesday. The SPY was up 1.00% to $519.02, while the QQQ declined 0.98% to $437.35, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Meanwhile, the dollar index was 0.15% higher at the 98.42 level.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44916388/chicago-fed-chair-goolsbee-agrees-with-bessent-fed-independence-is-a-jewel-box-awaits-tariff-revisit-before-jumping-to-action" target="_blank" rel="noreferrer noopener">Chicago Fed Chair Goolsbee Agrees With Bessent: ‘Fed Independence Is A Jewel Box,' Awaits Tariff Revisit Before ‘Jumping To Action'</a></li>
</ul>
Image: Shutterstock

Equities

Macro Economic Events

Macro Notification

Bonds

Treasuries

Economics

Markets

Wall Street Veteran Sounds Alarm On 'Never Before' Seen Market Trio: Falling Stocks, Surging Long Yields, Sinking Short Rates

Wells Fargo analyst Michael Turrin maintains Clearwater Analytics Hldg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CWAN#NYSE">CWAN</a>) with a Overweight and lowers the price target from $35 to $32.

CWAN

Wells Fargo Maintains Overweight on Clearwater Analytics Hldg, Lowers Price Target to $32

Evercore ISI Group analyst John Pancari downgrades Comerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) from In-Line to Underperform and lowers the price target from $65 to $50.

Downgrades

Evercore ISI Group Downgrades Comerica to Underperform, Lowers Price Target to $50

Wells Fargo analyst Michael Turrin maintains Blend Labs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLND#NYSE">BLND</a>) with a Overweight and lowers the price target from $6 to $5.

BLND

Wells Fargo Maintains Overweight on Blend Labs, Lowers Price Target to $5

Wells Fargo analyst Michael Turrin maintains Autodesk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) with a Overweight and lowers the price target from $350 to $345.

ADSK

Wells Fargo Maintains Overweight on Autodesk, Lowers Price Target to $345

Earnings

Earnings Misses

BCBP

BCB Bancorp Q1 2025 GAAP EPS $(0.51)

<a href="https://www.globenewswire.com/Tracker?data=o7V-0SsTOHcenMZhmD2dP3UDv-B6ZjmQQRaqf3TU9Xxc2D4W30ZgtSDO8Nzo8n8svBJUXmyQNpOH8OBE5UkRKUXO9jX6T6JGp6jXKDd4FsA=">Banzai International, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNZI#NASDAQ">BNZI</a>) ("Banzai" or the "Company"), a leading marketing technology company that provides essential marketing and sales solutions, today announced that it has issued 1,048,920 shares of common stock to Alco Investment Company ("Alco"), pursuant to an exercise notice for Pre-Funded Warrants received on September 20, 2024 for a purchase price of $3.89.
On September 20, 2024, the Company completed a private placement of securities pursuant to which Alco acquired 282,420 shares of Class A Common Stock for a purchase price of $3.89 per share, Pre-Funded Warrants to purchase up to 1,048,920 shares of Class A Common Stock with an exercise price of $0.0001 per share for a purchase price of $3.89 per Pre-Funded Warrant, and Common Warrants to purchase up to 1,331,340 shares of Class A Common Stock with an exercise price of $4.02 per share. Alco has not sold any shares issued under the private placement.
All Pre-Funded Warrants were net exercised on a cashless basis, resulting in a total number of Class A common shares outstanding of 14,470,727 as of April 21, 2025. Following the exercise, Alco will own 9.5% of the Company's Class A Common Stock.

Offerings

BNZI

Banzai Issues 1,048,920 Shares To Alco Investment Company, Bringing Alco's Ownership To 9.5% Of Outstanding Class A Common Stock As Total Shares Rise To 14.47M

Wells Fargo analyst Michael Turrin maintains Adobe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) with a Overweight and lowers the price target from $600 to $430.

ADBE

Wells Fargo Maintains Overweight on Adobe, Lowers Price Target to $430

Baird analyst Joe Vruwink maintains PTC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTC#NASDAQ">PTC</a>) with a Outperform and raises the price target from $181 to $185.

Baird Maintains Outperform on PTC, Raises Price Target to $185

Baird analyst Catherine Ramsey maintains Waters (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAT#NYSE">WAT</a>) with a Outperform and lowers the price target from $407 to $355.

Baird Maintains Outperform on Waters, Lowers Price Target to $355

Wells Fargo analyst Michael Turrin maintains 8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) with a Underweight and lowers the price target from $2 to $1.5.

EGHT

Wells Fargo Maintains Underweight on 8x8, Lowers Price Target to $1.5

Partnership to Feature Autonomous Drive-Thru with AI Technology and In-Suite Premium Coffee Integration
BREA, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Reborn Coffee Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REBN#NASDAQ">REBN</a>), a leader in the specialty coffee market, today announced that it has entered into a Memorandum of Understanding ("MOU") with Otonomus Hotel, marking a groundbreaking collaboration to reimagine the future of hospitality and retail coffee service.
The strategic partnership will bring together Reborn Coffee's specialty coffee expertise with Otonomus Hotel's pioneering AI-powered hospitality vision. At the heart of the collaboration is the co-development of a next-generation autonomous drive-thru coffee experience utilizing cutting-edge AI technology — an advanced, fully autonomous ordering and fulfillment system. The AI-enabled Reborn drive-thru will be prominently located at the front of the Otonomus Hotel, accessible to both hotel guests and the public.
In addition, the partnership will extend into every guest room with premium in-suite Reborn offerings, including cold brew cans, single-serve coffee capsules, and smart coffee machines. Select suites may also feature curated Reborn welcome kits for a personalized touch.
The MOU will remain in effect for an initial term of six months as both parties finalize operational and revenue-sharing details. The agreement is non-binding and subject to further definitive documentation.
 &nbsp;

REBN

Reborn Coffee Enters Into MoU With Otonomus Hotel To Launch AI-driven Hospitality Experience

Wells Fargo analyst Michael Berg maintains Sprinklr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CXM#NYSE">CXM</a>) with a Underweight and lowers the price target from $7 to $6.

Wells Fargo Maintains Underweight on Sprinklr, Lowers Price Target to $6

A Dose-Dependent Response in Body Weight Reduction Was Observed Between 8 mg and 32 mg Doses
Change in BMI and Body Weight Adjusted for Height In the Treatment Groups, Showed a Significant Difference Compared to Placebo, Indicating Potentially Greater Efficacy with Increasing Dosage and Longer Duration of Use
No Drug-Induced Cardiovascular Effects Were Observed In Heart Rate or QTcF Measurements of Subjects Receiving up to 32 mg of DA-1726 at 4-Weeks
Additional Cohorts Being Added to Determine Maximum Tolerated Dose
CAMBRIDGE, Mass., April 22, 2025 /PRNewswire/ -- MetaVia Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTVA#NASDAQ">MTVA</a>),&nbsp;a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today reported additional top-line results from the multiple ascending dose (MAD) Part 2 of its Phase 1 clinical trial of DA-1726, a novel, dual oxyntomodulin (OXM) analog agonist that functions as a glucagon-like peptide-1 receptor (GLP1R) and glucagon receptor (GCGR), further demonstrating its potential as a best-in-class obesity drug.
In the 28-day, 36-subject MAD portion of the study, a clear dose-responsive trend in body weight (BW) reduction was observed across the 8 mg to 32 mg range, indicating potentially greater efficacy at higher doses and longer duration of use. Additionally, body mass index (BMI), which shows body weight adjusted for height, showed a difference between the treatment group and the placebo (PBO) group, which was even more pronounced, further supporting the dose-dependent effect of the drug on weight-related outcomes. Of note, DA-1726 did not show any clinically significant increases in heart rate (HR) or QTcF changes up to 32 mg at 4 weeks of administration.
As previously reported, with no titration, DA-1726, with its novel 3:1 ratio between GLP-1R and GCGR at the 32 mg dose, demonstrated&nbsp;compelling maximum weight&nbsp;loss of -6.3% and mean weight loss of -4.3% at Day 26 (p=0.0005), while showing a strong signal of GLP-1R efficacy with maximum lowering of fasted glucose of -18 mg/dL&nbsp;and mean lowering of -5.3 mg/dL&nbsp;at Day 26,&nbsp;and maximum waist circumference reduction of 3.9 inches and mean reduction of 1.6 inches, indicating a strong signal of glucagon efficacy at Day 33.

Biotech

MTVA

MetaVia Reports Additional Top-Line Results From The MAD Part 2 Of Its Phase 1 Study Of DA-1726, A Novel 3:1 Ratio GLP-1 And Glucagon Dual Receptor Agonist To Treat Obesity; No Drug-Induced Cardiovascular Effects Were Observed In Heart Rate Or QTcF Measurements Of Subjects Receiving Up To 32mg Of DA-1726 At 4-Weeks; Additional Cohorts Being Added to Determine Maximum Tolerated Dose

Zions Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>) posted weaker-than-expected results for the <a href="https://www.benzinga.com/quote/ZION/earnings">first quarter on Monday</a>.
The company reported first-quarter revenue of $795 million, missing analyst estimates of $797.07 million, according to Benzinga Pro. The bank reported first-quarter earnings of $1.13 per share, missing analyst estimates of $1.17 per share.
"Credit quality remained in very good shape during the quarter, with nonperforming assets stable compared with last quarter at 0.51% of loans and leases and annualized net charge-offs of 0.11% of loans and leases. At the same time, the outlook for the economy is perhaps more uncertain than it's been in a number of years, clouded by the very real potential for negative impacts from tariffs and trade policy, both here and abroad," said Harris Simmons, chairman and CEO of Zions Bancorp.
Zions Bancorp shares dipped 1.5% to close at $43.62 on Monday.
These analysts made changes to their price targets on Zions Bancorp following earnings announcement.
<ul>
<li>Stephens &amp; Co. analyst Terry McEvoy maintained Zions Bancorp with an Equal-Weight rating and lowered the price target from $54 to $52.</li>
<li>Baird analyst David George maintained the stock with a Neutral rating and lowered the price target from $58 to $55.</li>
<li>Wells Fargo analyst Mike Mayo maintained Zions Bancorp with an Equal-Weight rating and cut the price target from $58 to $47.</li>
</ul>
Considering buying ZION stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="597" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/22083157/image-1-20-1024x597.png" alt="" class="wp-image-881789" style="width:662px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/22083157/image-1-20-1024x597.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/22083157/image-1-20-300x175.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/22083157/image-1-20-768x448.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/22083157/image-1-20.png 1106w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44896269/how-to-earn-500-a-month-from-3m-stock-ahead-of-q1-earnings">How To Earn $500 A Month From 3M Stock Ahead Of Q1 Earnings</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

ZION

These Analysts Lower Their Forecasts On Zions Bancorp After Downbeat Earnings

<a href="https://www.globenewswire.com/Tracker?data=6ooRSXKOQZ4CJWJdD6Tsqq4LjLykPLUcHYMMpFfgG7N9fD-Zh5bL3vAPFwP-UQSX7T9H9tOny3XPrYdw5eSlo6dqLr4RoB2bvYTBnVSdtNgyL4L-7zqefQl_gijny0u0">KULR Technology Group, Inc.</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KULR#NYSE">KULR</a>) (the "Company" or "KULR"), a leader in advanced energy management platforms, announced today that it has been awarded $6,703,500 by the Texas Space Commission as part of a $26 million grant award focused on strengthening Texas' leadership in space exploration and technology. The announcement was made public by the Commission and covered by <a href="https://www.globenewswire.com/Tracker?data=8XCuYTS-kdBRiisJoZgTsNEJNsEdiaXr0pQBlCaMbn7TIHjv-aydaFDjdel6LhGS5P2ba4KPdvKDaFlEcZn1zty8grgAIFOwvx87BaJIFBlLO-fdfLCLKaxyQUQZqQxoAFxCz1v0NByQysieFteHXBB1jTzn5KTzvcPRLRRNJYA=">SpaceNews</a>.
KULR's selection supports its role in an ambitious program to develop cold-temperature lithium-ion battery solutions for the next generation of Lunar and Martian missions. The initiative is being carried out in close collaboration with <a href="https://www.globenewswire.com/Tracker?data=oMgvYznLtJqnX0zwVdVBYfucZWDeJzpnwj4Ui_XbKEx6kLNuQ-LWkOPRCX9hCEKRXkEHSEVUL04NizyXZ3q-DXoVQyJK8AScOllaFiYtyp9X2QfM8flnXGMvxQFPRPgE">NASA Johnson Space Center</a> (JSC) and in partnership with <a href="https://www.globenewswire.com/Tracker?data=ENC6hdmbd5YUHK7ytodbLzoWWmu8D3TF1PyCRB_gwAjb2kl6hK6YPvTD6-ClvEwqzp5LgitktcpI2NWfK-srquKDI1cmkwWXPPwWDda2Vco=">South 8 Technologies</a>, aligning public, private, and academic stakeholders to deliver scalable, space-rated battery technology.
"This award underscores KULR's commitment to powering the next era of space exploration with safe, high-performance, and environmentally adaptive KULR ONE Space platform," said Michael Mo, CEO of KULR Technology Group. "Working alongside visionary partners at NASA JSC and South 8, we're proud to anchor this Texas-led effort to develop scalable, space-rated battery technology that advances national objectives and commercial innovation."
Throughout the program, KULR will manage the design, testing, and production of lithium-ion cells using liquefied gas (LiGas) electrolyte from South 8 Technologies. These cells will operate down to -60°C and be integrated into the KULR ONE Space platform, optimized for extreme environments encountered during lunar and Martian missions.
Located just minutes from NASA Johnson Space Center, KULR's Webster, TX facility will serve as the engineering and test hub for this effort, performing advanced battery safety testing and performance validation. The project aligns with NASA's Artemis objectives by reducing heater energy requirements, improving safety margins, and enabling longer-duration operations in deep space environments.

Financing

KULR

Kulr Technology Awarded Over $6.7M By Texas Space Commission As Part Of $26M Grant Award Focused On Strengthening Texas' Leadership In Space Exploration And Technology

President Donald Trump held a meeting with the CEOs of Walmart Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>), Home Depot Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>), and Target Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) on Monday.
What Happened: The meeting was centered around the possible effects of Trump&#8217;s wide-ranging tariff plans on the import-centric business models of these retail behemoths. Walmart&#8217;s CEO Doug McMillon, Target CEO Brian Cornell, and Home Depot&#8217;s Ted Decker attended the meeting, <a href="https://www.cnbc.com/2025/04/21/trump-tariffs-walmart-home-depot-lowes-target.html">CNBC </a>reported.
Despite initial reports of a representative from&nbsp;Lowe&#8217;s Companies Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOW#NYSE">LOW</a>) attending, it was later confirmed that Lowe&#8217;s was not represented at the meeting.
Post-meeting, the three companies issued similar statements, expressing gratitude for the opportunity to share their insights with the President and his team. They pledged their commitment&nbsp;to delivering value for American&nbsp;consumers and expressed eagerness to continue the dialogue. 
President Trump later expressed satisfaction with the meeting, stating it was an honor to host the retail leaders in the Oval Office.
David French, the executive vice president for government relations at the National Retail Federation, previously told the New York Times, "The deal window may be open.&#8221;
SEE ALSO:&nbsp;<a href="https://benzinga.com/markets/25/04/44916042/general-motors-has-no-plans-to-move-ev-production-away-from-mexico-despite-tariff-uncertainty" target="_blank" rel="noreferrer noopener">General Motors Has No Plans To Move EV Production Away From Mexico Despite Tariff Uncertainty</a>
Why It Matters: Walmart sources about one-third of its products globally, with China and Mexico being the most significant suppliers. Meanwhile, Target, known for affordable fashion and home goods, primarily relies on overseas manufacturing for these items. For these retailers, tariffs present a new hurdle in an already challenging economic environment, where consumers are seeking low prices amidst high inflation.
Leading industry lobbying groups from agriculture, construction, manufacturing, retail, and tech are urging the White House to ease more tariffs, arguing that certain products are too costly or impractical to produce domestically and must be imported. Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) CEO Tim Cook reportedly <a href="https://www.benzinga.com/25/04/44882019/apple-ceo-tim-cooks-dialogue-with-commerce-secretary-lutnick-secured-tariff-exemption-for-iphones-and-electronics-report">negotiated </a>with the White House and obtained relief for both his company and the wider electronics industry. Trump also later stated that he &#8216;helped&#8217; the CEO and his business. 
Nevertheless, earlier this month,&nbsp;<a href="https://www.benzinga.com/news/guidance/25/04/44711688/walmart-maintains-steady-growth-forecast-despite-tariffs">Walmart</a>&nbsp;reaffirmed its first-quarter guidance, indicating steady sales growth despite the looming tariffs. The retail giant continues to project a sales growth of 3% – 4% in constant currencies for the first quarter of FY26.
Meanwhile, a recent&nbsp;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44797563/goldman-sachs-sees-upside-in-retail-giants-dollar-tree-home-depot-best-buy-and-target-despite-tariff-margin-pressures">Goldman Sachs analysis</a>&nbsp;highlighted the potential impact of China tariffs on profitability for Home Depot and Target. The report suggests that despite tariff and margin pressures, there might be an upside for these retail giants.
Benzinga's Edge Rankings&nbsp;highlight strong momentum and growth rankings for Walmart in the 94th and 55th percentiles, respectively. Curious how other stocks stack up?&nbsp;<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound" target="_blank" rel="noreferrer noopener">Click here</a>&nbsp;to uncover growth and momentum scores for top stocks.
<ul>
<li>READ MORE:&nbsp;<a href="https://benzinga.com/markets/cryptocurrency/25/04/44917155/xrp-leads-ethereum-bleeds-as-crypto-investment-products-see-6-million-in-inflows" target="_blank" rel="noreferrer noopener">XRP Leads, Ethereum Bleeds As Crypto Investment Products See $6 Million In Inflows &#8211; Benzinga</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

AAPL

Trump Meets With Walmart, Home Depot And Target CEOs To Discuss Tariff Impacting Consumer Prices

Press Releases

IQVIA to Announce Fourth-Quarter and Full-Year 2024 Results on February 6, 2025

IQVIA named to the Fortune® World's Most Admired Companies™ list, ranked No. 1 in its sector for fourth consecutive year

IQVIA Reports Fourth-Quarter and Full-Year 2024 Results; Reaffirms Full-Year 2025 Guidance

IQVIA Releases 2024 Sustainability Report

IQVIA CFO Ron Bruehlman to Speak at the TD Cowen Annual Health Care Conference on March 4, 2025

IQVIA AI Assistant wins 2024 PM360 Innovation Award for Artificial Intelligence

IQVIA Laboratories launches Site Lab Navigator with breakthrough e-Requisition innovation to transform clinical trials

IQVIA recognized as a leader in IDC MarketScape's 2024 assessment for decentralized clinical trial technologies and consulting services

Stabilization and improvement seen in multiple key biopharma R&D metrics, says IQVIA Institute Report

IQVIA to Announce First-Quarter 2025 Results on May 6, 2025

Agilent Technologies

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Avantor

Azenta

Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories

Bio-Rad Laboratories, Inc. Class B Common Stock

BioLife Solutions

Bruker

Charles River Laboratories International, Inc. Common Stock

Charles River

Danaher

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Comments

IQVIA Hldgs

Noticias

Últimas noticias sobre IQVIA Hldgs (NYSE:IQV) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL